To Reduce the Deficit, Tariff the Money
To reduce the deficit in a durable way, the United States must do more than tariff goods. It must tariff the money.
To reduce the deficit in a durable way, the United States must do more than tariff goods. It must tariff the money.
The development of GTAP-USL economic model marks another step forward in our efforts to make the GTAP more realistic and a better predictor of the real-world effects of trade policies or trade shocks. It’s critical to build models that provide a better understanding of how policies impact people, families, racial groups, gender, cities and regions. There is still more work to be done.
The overall goods and services deficit number for January looked pretty good – coming in at $54.4 billion, its lowest monthly point in years. But when services are stripped from the equation, the goods trade looks like it has returned to level footing. January’s goods deficit was $81.7 billion, according to Thursday’s trade data from the Bureau of Economic Analysis.
The free trade, foreign policy apparatus on Capitol Hill is openly advocating for the extension of the African Growth and Opportunity Act (AGOA), with senior committee leaders from both parties coming out in favor of it during a March 3 Center for Strategic and International Studies event about the trade deal’s future.
Last year, Americans spent more than $15 billion on Novo Nordisk’s diabetes and weight-loss drugs Ozempic and Wegovy. The active ingredient in both treatments — semaglutide— has rapidly become one of the world’s most commercially successful medicines.
Cheap imports shaved prices on some goods but never made Americans richer. Wage losses and job destruction outweighed any discounts.
On Capitol Hill, the defense narrative clearly gets legislators’ attention. It remains the surest way to get Members of Congress thinking about reindustrialization and rebuilding domestic supply chains.
President Trump has made American reindustrialization and reshoring central to his economic policy agenda. Reviving American manufacturing enjoys broad public support and has increasingly become a bipartisan priority.
The Senate Finance Committee agrees on two things: First, the U.S. Mexico and Canada Agreement (USMCA) isn’t perfect and a number of issues need fixing. Second, they don’t want tariffs.
Zydus Pharmaceuticals, one of India’s largest generic drug makers, recalled over 22,000 bottles of a cholesterol medication on Dec. 30, 2025. AvKare, a Tennessee-based pharmaceuticals distribution company that relies on imports, recalled around 7,900 cartons of Rosuvastatin, a widely used generic statin, a day later.